Ibrutinib, a Bruton's tyrosine kinase inhibitor used for treatment of lymphoproliferative disorders, eliminates both aeroallergen skin test and basophil activation test reactivity

Jennifer A. Regan, Yun Cao, Melanie C. Dispenza, Shuo Ma, Leo I. Gordon, Adam M. Petrich, Bruce S. Bochner

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)875-879.e1
JournalJournal of Allergy and Clinical Immunology
Volume140
Issue number3
DOIs
StatePublished - Sep 2017

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this